{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:48:12Z","timestamp":1775278092499,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Comparative Pathology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jcpa.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T01:05:29Z","timestamp":1542675929000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of Histological, Immunohistochemical, Clinical and Genetic Prognostic Factors Associated with the Response of Canine Mast Cell Tumours to Glucocorticotherapy"],"prefix":"10.1016","volume":"165","author":[{"given":"R.","family":"dos Santos Horta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Eunice Lavalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Narducci Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.B.T.M.","family":"Alves dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de P\u00e1dua Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dantas Cassali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcpa.2018.10.001_bib1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2460\/javma.1999.215.11.1629","article-title":"Immunohistochemical detection of proliferating cell nuclear antigen and Ki67 in mast cell tumors from dogs","volume":"215","author":"Abadie","year":"1999","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.jcpa.2018.10.001_bib2","series-title":"On the Constitutional and Local Effects of Disease of the Supra-renal Capsules","author":"Addison","year":"1855"},{"key":"10.1016\/j.jcpa.2018.10.001_bib3","first-page":"189","article-title":"Human lymphoid cell lines and glucocorticoids: II. Whole cell and cytoplasmic binding properties of lymphoblastoid, leukaemia and lymphoma lines","volume":"4","author":"Barrett","year":"1981","journal-title":"Diagnostic Histopathology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1476-5829.2012.00341.x","article-title":"European consensus document of mast cell tumours in dogs and cats","volume":"10","author":"Blackwood","year":"2012","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3181\/00379727-79-19475","article-title":"Effects of cortisone on canine mast cell tumor","volume":"80","author":"Bloom","year":"1952","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1200\/JCO.1984.2.4.323","article-title":"Glucocorticoid receptors in leukemia and lymphoma","volume":"2","author":"Bloomfield","year":"1984","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1476-5829.2006.00125.x","article-title":"Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997\u20132004)","volume":"5","author":"Camps-Palau","year":"2007","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5326\/0400124","article-title":"Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors","volume":"40","author":"Davies","year":"2004","journal-title":"Journal of the American Animal Hospital Association"},{"key":"10.1016\/j.jcpa.2018.10.001_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1476-5810.2004.00048.x","article-title":"Treatment of canine mast cell tumours with prednisolone and radiotherapy","volume":"2","author":"Dobson","year":"2004","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1748-5827.2007.00366.x","article-title":"Advances in the diagnosis and management of cutaneous mast cell tumours in dogs","volume":"48","author":"Dobson","year":"2007","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib10","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1124\/dmd.109.031302","article-title":"Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib","volume":"38","author":"Dohse","year":"2010","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.jcpa.2018.10.001_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3181\/00379727-53-14219P","article-title":"Effect of pituitary adrenotrophic hormone on lymphoid tissue","volume":"53","author":"Dougherty","year":"1943","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archinte.1950.00230100002001","article-title":"Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions","volume":"85","author":"Hench","year":"1950","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0300985817747325","article-title":"Assessment of canine mast cell tumor mortality risk based on clinical, histologic, immunohistochemical, and molecular features","volume":"55","author":"Horta","year":"2018","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signaling in health and disease","volume":"34","author":"Kadmiel","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.jcpa.2018.10.001_bib15","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.M113.473819","article-title":"Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) alpha and activator protein 1 (AP1) in dexamethasone-mediated interference of ER\u03b1 activity","volume":"288","author":"Karmakar","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jcpa.2018.10.001_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1748-5827.2011.01093.x","article-title":"Mast cell tumour and cutaneous histiocytoma excision wound healing in general practice","volume":"52","author":"Killick","year":"2011","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0300985810386469","article-title":"Proposal of 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior","volume":"48","author":"Kiupel","year":"2011","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1354\/vp.41-4-371","article-title":"The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors","volume":"41","author":"Kiupel","year":"2004","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib20","first-page":"994","article-title":"Mechanisms of glucocorticoid resistance in human leukemic cells: implication of abnormal 90 and 70 kDa heat shock proteins","volume":"10","author":"Kojika","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.jcpa.2018.10.001_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.steroids.2016.02.019","article-title":"New dimension of glucocorticoids in cancer treatment","volume":"111","author":"Lin","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.jcpa.2018.10.001_bib22","series-title":"Withrow and MacEwen's Small Animal Clinical Oncology","first-page":"335","article-title":"Mast cell tumors","author":"London","year":"2013"},{"key":"10.1016\/j.jcpa.2018.10.001_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0021-9258(18)74790-X","article-title":"The chemistry of crystalline substances isolated from the suprarenal gland","volume":"114","author":"Mason","year":"1936","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.jcpa.2018.10.001_bib24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1939-1676.1994.tb03259.x","article-title":"Response of canine mast cell tumours to treatment with oral prednisolone","volume":"8","author":"McCaw","year":"1994","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvim.12525","article-title":"P-glycoprotein mediated drug interactions in animals and humans with cancer","volume":"29","author":"Mealey","year":"2015","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/vco.12032","article-title":"Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document","volume":"13","author":"Nguyen","year":"2015","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1398-9995.2011.02731.x","article-title":"PEST-domain enriched tyrosine phosphatase and glucocorticoids as regulators of anaphylaxis in mice","volume":"67","author":"Obiri","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jcpa.2018.10.001_bib28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0195-5616(90)50087-X","article-title":"Canine mast cell tumours","volume":"20","author":"O'Keefe","year":"1990","journal-title":"Veterinary Clinics of North America: Small Animal Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2013.05.014","article-title":"Molecular mechanisms of glucocorticoid action in mast cells","volume":"380","author":"Oppong","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/030098588402100503","article-title":"Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs","volume":"21","author":"Patnaik","year":"1984","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib31","first-page":"306","article-title":"Steroid receptor interactions with heat shock protein and immunophilin chaperones","volume":"18","author":"Pratt","year":"1997","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.jcpa.2018.10.001_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1939-1676.1999.tb02217.x","article-title":"Treatment of canine mast cell tumors with CCNU (lomustine)","volume":"13","author":"Rassnick","year":"1999","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2174\/1566524033479357","article-title":"A conceptual view on glucocorticoid-induced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia","volume":"3","author":"Renner","year":"2003","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib34","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0195-5616(96)50008-2","article-title":"Mast cell tumors: dilemmas of diagnosis and treatment","volume":"26","author":"Rogers","year":"1996","journal-title":"Veterinary Clinics of North America: Small Animal Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1354\/vp.44-3-335","article-title":"Mitotic index is predictive for survival for canine cutaneous mast cell tumors","volume":"44","author":"Romansik","year":"2007","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib37","first-page":"80","article-title":"Steroid therapy","author":"Rozanski","year":"2010","journal-title":"Clinician's Brief"},{"key":"10.1016\/j.jcpa.2018.10.001_bib39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-12-2350","article-title":"FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells","volume":"73","author":"Sahu","year":"2013","journal-title":"Cancer Research"},{"key":"10.1016\/j.jcpa.2018.10.001_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1939-1676.2006.tb02835.x","article-title":"Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis","volume":"20","author":"Scase","year":"2006","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/JOE-11-0135","article-title":"Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells","volume":"211","author":"Schlossmacher","year":"2011","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401456","article-title":"Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance","volume":"11","author":"Schmidt","year":"2004","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/j.jcpa.2018.10.001_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/vco.12346","article-title":"Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs","volume":"16","author":"Shaw","year":"2018","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mce.2005.11.012","article-title":"Non-genomic glucocorticoid effects to provide the basis for new drug developments","volume":"246","author":"Song","year":"2006","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib44","first-page":"1038","article-title":"Corticosteroid","volume":"Vol. 1","author":"Spoelhoef","year":"2014"},{"key":"10.1016\/j.jcpa.2018.10.001_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2460\/javma.232.1.53","article-title":"Evaluation of neoadjuvant prednisolone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs","volume":"232","author":"Stanclift","year":"2008","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.jcpa.2018.10.001_bib46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hlca.193702001158","article-title":"Desoxy-cortico-sterone (21-Oxy-progesteron) aus \u03945 -3Oxy-\u00e4tio-cholens\u00e4ure","volume":"20","author":"Steiger","year":"1937","journal-title":"Helvetic Chimica Acta"},{"key":"10.1016\/j.jcpa.2018.10.001_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0025-6196(25)08374-0","article-title":"Cortisone and ACTH in the management of leukemia and lymphoblastoma","volume":"25","author":"Stickney","year":"1950","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.jcpa.2018.10.001_bib48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1292\/jvms.59.995","article-title":"Inhibitory effects of glucocorticoids on proliferation of canine mast cell tumor","volume":"59","author":"Takahashi","year":"1997","journal-title":"Journal of Veterinary Medical Science"},{"key":"10.1016\/j.jcpa.2018.10.001_bib49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1748-5827.2009.00732.x","article-title":"Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases","volume":"50","author":"Taylor","year":"2009","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib50","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jsap.12320","article-title":"Comparison between Ki67 index and mitotic index for predicting outcome in canine mast cell tumours","volume":"56","author":"Van Lelyveld","year":"2015","journal-title":"Journal of Small Animal Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/vco.283","article-title":"Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0","volume":"14","year":"2016","journal-title":"Veterinary and Comparative Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3949\/ccjm.59.5.505","article-title":"Glucocorticoids in clinical oncology","volume":"59","author":"Walsh","year":"1992","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1016\/j.jcpa.2018.10.001_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/inp.h3440","article-title":"Canine mast cell tumours: decision-making and treatment","volume":"37","author":"Warland","year":"2015","journal-title":"In Practice"},{"key":"10.1016\/j.jcpa.2018.10.001_bib54","first-page":"225","article-title":"Corticosteroids in advanced cancer","volume":"15","author":"Wooldridge","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.jcpa.2018.10.001_bib55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucocorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmunity Reviews"}],"container-title":["Journal of Comparative Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021997518302263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021997518302263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:52:36Z","timestamp":1775274756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021997518302263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":54,"alternative-id":["S0021997518302263"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpa.2018.10.001","relation":{},"ISSN":["0021-9975"],"issn-type":[{"value":"0021-9975","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Histological, Immunohistochemical, Clinical and Genetic Prognostic Factors Associated with the Response of Canine Mast Cell Tumours to Glucocorticotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Comparative Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpa.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}